CCR5 and neoplasm: [28] reported that CCL4/CCL5 can interact with its receptor CCR5 and promote the recruitment of γδ‐T cells from the peripheral blood or surrounding tumor to the tumor area, thereby increasing the number of γδT cells in the tumor and improving the anti‐tumor immunity of γδ T cells and the prognosis of the patient.